Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Thursky

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Expert Review of Anti-Infective Therapy|June 15, 2006
Use of computerized decision support systems to improve antibiotic prescribingKarin Thursky
Current Opinion in Infectious Diseases|October 9, 2012
Dosing of antibiotics in obesityBrett Janson, Karin Thursky
Australian Journal of General Practice|January 31, 2022
Editorial: Antibiotics - Keeping the miracle alivePaul Glasziou, Karin Thursky
Leukemia & Lymphoma|July 24, 2019
Mold-active prophylaxis in acute leukemia: not enough of a good thing?<sup></sup>Emma Paige, Karin Thursky, Monica Slavin
Seminars in Respiratory and Critical Care Medicine|August 10, 2005
Epidemiology, prevalence, and sites of infections in intensive care unitsMichael Richards, Karin Thursky, Kirsty Buising
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 18, 2022
Auditing tools for antimicrobial prescribing in solid organ transplant recipients: The why, the how, and an assessment of current optionsMiranda So, Yoshiko Nakamachi, Karin Thursky
Current Opinion in Infectious Diseases|August 10, 2022
New approaches to management of fever and neutropenia in high-risk patientsAbby Douglas, Karin Thursky, Monica Slavin
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|November 27, 2025
Applying the Learning Health System framework to overcome barriers in antimicrobial decision support: lessons from the Guidance redesignJenna Maleki, Lisa Hall, Karin Thursky
Leukemia & Lymphoma|June 19, 2013
Very late onset hepatitis-B virus reactivation following rituximab despite lamivudine prophylaxis: the need for continued vigilanceEdward Chew, Karin Thursky, John F Seymour
Pharmacoeconomics|March 14, 2019
Incorporating Future Medical Costs: Impact on Cost-Effectiveness Analysis in Cancer PatientsMichelle Tew, Philip Clarke, Karin Thursky, et al.
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Expert Review of Anti-Infective Therapy|June 15, 2006
Use of computerized decision support systems to improve antibiotic prescribingKarin Thursky
Current Opinion in Infectious Diseases|October 9, 2012
Dosing of antibiotics in obesityBrett Janson, Karin Thursky
Australian Journal of General Practice|January 31, 2022
Editorial: Antibiotics - Keeping the miracle alivePaul Glasziou, Karin Thursky
Leukemia & Lymphoma|July 24, 2019
Mold-active prophylaxis in acute leukemia: not enough of a good thing?<sup></sup>Emma Paige, Karin Thursky, Monica Slavin
Seminars in Respiratory and Critical Care Medicine|August 10, 2005
Epidemiology, prevalence, and sites of infections in intensive care unitsMichael Richards, Karin Thursky, Kirsty Buising
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 18, 2022
Auditing tools for antimicrobial prescribing in solid organ transplant recipients: The why, the how, and an assessment of current optionsMiranda So, Yoshiko Nakamachi, Karin Thursky
Current Opinion in Infectious Diseases|August 10, 2022
New approaches to management of fever and neutropenia in high-risk patientsAbby Douglas, Karin Thursky, Monica Slavin
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|November 27, 2025
Applying the Learning Health System framework to overcome barriers in antimicrobial decision support: lessons from the Guidance redesignJenna Maleki, Lisa Hall, Karin Thursky
Leukemia & Lymphoma|June 19, 2013
Very late onset hepatitis-B virus reactivation following rituximab despite lamivudine prophylaxis: the need for continued vigilanceEdward Chew, Karin Thursky, John F Seymour
Pharmacoeconomics|March 14, 2019
Incorporating Future Medical Costs: Impact on Cost-Effectiveness Analysis in Cancer PatientsMichelle Tew, Philip Clarke, Karin Thursky, et al.
Pageof 13